Transfection optimization for primary human CD8+ cells

Journal of Immunological Methods

Volumn 372, Issue 1-2, 2011, Pages 22-29

  Liu, Lianxing ^a   Johnson, Carl ^a   Fujimura, Sue ^a   Teque, Fernando ^a   Levy, Jay A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Electroporation; HIV 1; Primary human CD8+ cells; Transfection

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON 8; CD8 ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; ELECTROPORATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CD8-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; ELECTROPORATION; FLOW CYTOMETRY; GENE THERAPY; HIV-1; HUMANS; INTERFERON-ALPHA; MICROSCOPY, CONFOCAL; PLASMIDS; TRANSFECTION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80052430242     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2011.06.026     Document Type: Article

References (21)

1. Al-Dosari M.S., Gao X. Nonviral gene delivery: principle, limitations, and recent progress. AAPS J. 2009, 11:671.
2. Andreason G.L., Evans G.A. Optimization of electroporation for transfection of mammalian cell lines. Anal. Biochem. 1989, 180:269.
3. Barker E., Mackewicz C.E., Reyes-Teran G., Sato A., Stanford S., Fujimura S.H., Christopherson C., Chang S.Y., Levy J.A. Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome. Blood 1998, 92:3105.
4. Cocchi F., DeVico A.L., Garzino-Demo A., Arya S.K., Gallo R.C., Lusso P. Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995, 270:1811.
5. Hamm A., Krott N., Breibach I., Blindt R., Bosserhoff A.K. Efficient transfection method for primary cells. Tissue Eng. 2002, 8:235.
6. Hoffman A.D., Banapour B., Levy J.A. Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology 1985, 147:326.
7. Koup R.A., Ho D.D. Shutting down HIV. Nature 1994, 370:416.
8. Levy J.A., Mackewicz C.E., Barker E. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol. Today 1996, 17:217.
9. Lifson J.D., Rossio J.L., Piatak M., Parks T., Li L., Kiser R., Coalter V., Fisher B., Flynn B.M., Czajak S., Hirsch V.M., Reimann K.A., Schmitz J.E., Ghrayeb J., Bischofberger N., Nowak M.A., Desrosiers R.C., Wodarz D. Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment. J. Virol. 2001, 75:10187.
10. Mackewicz C.E., Ortega H., Levy J.A. The anti-HIV activity in CD8+ cell culture fluids is not associated with other known cytokines. Cell Immunol. 1994, 153:329.
11. Mir L.M. Application of electroporation gene therapy: past, current, and future. Methods Mol. Biol. 2008, 423:3.
12. Mir L.M., Bureau M.F., Gehl J., Rangara R., Rouy D., Caillaud J.M., Delaere P., Branellec D., Schwartz B., Scherman D. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc. Natl. Acad. Sci. USA 1999, 96:4262.
13. Neumann E., Schaefer-Ridder M., Wang Y., Hofschneider P.H. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J. 1982, 1:841.
14. Ogg G.S., Jin X., Bonhoeffer S., Dunbar P.R., Nowak M.A., Monard S., Segal J.P., Cao Y., Rowland-Jones S.L., Cerundolo V., Hurley A., Markowitz M., Ho D.D., Nixon D.F., McMichael A.J. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998, 279:2103.
15. Romano G. Current development of nonviral-mediated gene transfer. Drug News Perspect. 2007, 20:227.
16. Schaffer D.V., Koerber J.T., Lim K.I. Molecular engineering of viral gene delivery vehicles. Annu. Rev. Biomed. Eng. 2008, 10:169.
17. Sukharev S.I., Klenchin V.A., Serov S.M., Chernomordik L.V., Chizmadzhev Yu A. Electroporation and electrophoretic DNA transfer into cells. The effect of DNA interaction with electropores. Biophys. J. 1992, 63:1320.
18. Titomirov A.V., Sukharev S., Kistanova E. In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochim. Biophys. Acta 1991, 1088:131.
19. Walker C.M., Erickson A.L., Hsueh F.C., Levy J.A. Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism. J. Virol. 1991, 65:5921.
20. Walker C.M., Moody D.J., Stites D.P., Levy J.A. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986, 234:1563.
21. Zhang X., Godbey W.T. Viral vectors for gene delivery in tissue engineering. Adv. Drug Deliv. Rev. 2006, 58:515.